Comparing the efficacy of different dexamethasone regimens for maintenance treatment of multiple myeloma in standard-risk patients non-eligible for transplantation

doi:10.12998/wjcc.v10.i32.11712

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 32

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3025)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-6) series.

Item

Count

PDF

142

WORD

HTML

1366

Figures (1-1)

332

Tables (1-6)

207

Sum=2090

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

237

Download

698

Sum=935

Nov 16, 2022 (publication date) through Nov 4, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Control Study

World J Clin Cases. Nov 16, 2022; 10(32): 11712-11725
Published online Nov 16, 2022. doi: 10.12998/wjcc.v10.i32.11712

Table 5 Multivariate Cox’s proportional hazard regression analysis of factors affecting overall survival

Parameters	P value	HR	95%CI
Parameters	P value	HR	Lower	Higher
Age, yr	0	1.107	1.048	1.170
ISS stage	0	3.707	1.798	7.643
t(11;14)	0.055	0.399	0.156	1.019
IFG	0.246	0.482	0.140	1.655

IFG: Impaired fasting glucose.

Citation: Hu SL, Liu M, Zhang JY. Comparing the efficacy of different dexamethasone regimens for maintenance treatment of multiple myeloma in standard-risk patients non-eligible for transplantation. World J Clin Cases 2022; 10(32): 11712-11725
URL: https://www.wjgnet.com/2307-8960/full/v10/i32/11712.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i32.11712